Cytokinetics, Incorporated (CYTK)
Market: NASD |
Currency: USD
Address: 350 Oyster Point Boulevard
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. It develops small molecule drug candidates primarily engineered to impact muscle function and contractility. The company's drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure. It also develops CK-136, a novel cardiac troponin activator that is in Phase I clinical trial; CK-586, a small molecule cardiac myosin inhibitor, that is in Phase I clinical trial; and aficamten, a novel cardiac myosin inhibitor, which is in Phase III clinical trial for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy. The company has a strategic alliance with Ji Xing Pharmaceuticals Limited; and a collaboration and license agreement for the development and commercialization of aficamten in Japan for the treatment of patients with obstructive and non-obstructive hypertrophic cardiomyopathy. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Show more
📈 Cytokinetics, Incorporated Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$71.60
-
Upside/Downside from Analyst Target:
118.76%
-
Broker Call:
36
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
0-10%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
200-500%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for Cytokinetics, Incorporated
Date | Reported EPS |
---|
2026-05-04 (estimated upcoming) | - |
2026-02-25 (estimated upcoming) | - |
2025-11-04 (estimated upcoming) | - |
2025-11-03 (estimated upcoming) | - |
2025-08-06 (estimated upcoming) | - |
2025-08-05 (estimated upcoming) | - |
2025-05-06 | -1.39 |
2025-05-05 | - |
2025-02-27 | -1.26 |
2024-11-06 | -1.36 |
2024-08-08 | -1.31 |
2024-08-07 | -1.31 |
2024-05-08 | -1.33 |
2024-05-07 | -1.33 |
2024-02-27 | -1.38 |
2024-02-26 | -1.38 |
2023-11-02 | -1.35 |
2023-11-01 | -1.35 |
2023-08-03 | -1.34 |
2023-08-02 | -1.34 |
2023-05-04 | -1.38 |
2023-05-03 | -1.38 |
2023-03-01 | -1.45 |
2023-02-28 | -1.45 |
2022-11-03 | -1.52 |
2022-11-02 | -1.52 |
2022-08-04 | -0.23 |
2022-08-03 | -0.23 |
2022-05-04 | -1.02 |
2022-05-03 | -1.02 |
2022-02-24 | -0.36 |
2022-02-23 | -0.36 |
2021-11-03 | -0.95 |
2021-11-02 | -0.95 |
2021-08-05 | -0.86 |
2021-08-04 | -0.86 |
2021-05-06 | -0.66 |
2021-05-05 | -0.66 |
2021-02-25 | -0.62 |
2021-02-24 | -0.62 |
2020-11-04 | -0.05 |
2020-11-03 | -0.05 |
2020-08-06 | -0.68 |
2020-08-05 | -0.68 |
2020-05-06 | -0.66 |
2020-05-05 | -0.66 |
2020-03-03 | -0.52 |
2020-03-02 | -0.52 |
2019-10-30 | -0.5 |
2019-08-07 | -0.56 |
2019-05-08 | -0.54 |
2019-02-20 | -0.48 |
2018-10-31 | -0.4 |
2018-07-25 | -0.51 |
2018-04-25 | -0.56 |
2018-02-14 | -0.75 |
2017-10-25 | -0.6 |
2017-08-01 | -0.6 |
2017-04-26 | -0.62 |
2017-02-15 | 0.16 |
2016-10-26 | 0.74 |
2016-07-27 | -0.29 |
2016-04-27 | -0.31 |
2016-02-15 | -0.24 |
2015-10-28 | -0.23 |
2015-07-28 | -0.27 |
2015-04-29 | -0.23 |
2015-02-11 | 0.23 |
2014-10-29 | -0.16 |
2014-07-29 | -0.23 |
2014-05-05 | -0.27 |
2014-02-05 | 0.21 |
2013-10-29 | -0.43 |
2013-07-30 | -0.58 |
2013-04-29 | -0.54 |
2013-02-04 | -0.42 |
2012-10-29 | -0.42 |
2012-07-30 | -0.78 |
2012-04-25 | -0.78 |
2012-02-01 | -0.96 |
2011-10-26 | -0.9 |
2011-07-27 | -1.38 |
2011-04-26 | -1.08 |
2011-02-13 | -1.02 |
2010-10-27 | -1.14 |
2010-07-27 | -1.26 |
2010-04-28 | -1.2 |
2010-02-02 | -1.26 |
2009-10-27 | -0.84 |
2009-07-28 | 5.94 |
2009-04-29 | -1.26 |
2009-02-09 | -1.32 |
2008-10-29 | -1.98 |
2008-07-30 | -1.86 |
2008-04-28 | -1.68 |
2008-01-30 | -1.62 |
2007-10-30 | -1.44 |
2007-07-30 | -1.62 |
2007-04-25 | -1.5 |
2007-01-30 | -2.46 |
2006-10-25 | -2.46 |
2006-07-26 | -2.22 |
2006-04-26 | -2.16 |
2006-01-30 | -2.28 |
2005-10-25 | -2.1 |
2005-07-26 | -2.22 |
2005-04-26 | -2.22 |
2005-02-02 | -2.52 |
2004-10-20 | -2.16 |
📰 Related News & Research
No related articles found for "cytokinetics incorporated".